401 filings
Page 6 of 21
8-K
2ujc5dm8
25 Oct 07
Imclone Systems Reports Third Quarter 2007 Financial Results
12:00am
8-K
tjr3gt
18 Oct 07
Imclone and Bristol-myers Squibb Announce Joint Agreement
12:00am
S-8
3gcwupw5tnt3kpx
9 Oct 07
Registration of securities for employees
12:00am
8-K
9lntl8jhq8
4 Oct 07
Other Events
12:00am
8-K
9m42rp
28 Sep 07
Departure of Directors or Principal Officers
12:00am
CORRESP
4v7fvvirv75v0vl ny
21 Sep 07
Correspondence with SEC
12:00am
8-K
f4zy3f
11 Sep 07
Other Events
12:00am
8-K
7mn4d
10 Sep 07
Other Events
12:00am
8-K
ylhx9ay0myvjb
29 Aug 07
Departure of Directors or Principal Officers
12:00am
8-K
sx8ms8pjebmy
24 Aug 07
Fda Approves Imclone Systems’ New State-of-the-art Manufacturing Facility
12:00am
8-K
qpygbr4sm7yeue
23 Aug 07
Departure of Directors or Principal Officers
12:00am
8-K
ppt91w
10 Aug 07
Imclone Systems Appoints John H. Johnson Chief Executive Officer
12:00am
8-K
zl9gi0gg
31 Jul 07
Imclone Systems Reports Second Quarter 2007 Financial Results
12:00am
8-K
g5p 5onwerr
30 Jul 07
Bristol-myers Squibb and Imclone Systems Significantly Expand Erbitux Clinical Development Program
12:00am
8-K
rdphwkxsjjmgs
13 Jul 07
Other Events
12:00am
8-K
pgvpgmbuy
10 Jul 07
Departure of Directors or Principal Officers
12:00am
8-K
pq27c3jz0dknaqk
8 Jun 07
Extensive Clinical Data on Erbitux® Presented at the 2007 Asco Annual Meeting
12:00am